Tags: Cervical | Cancer | Vaccine | Effective

Cervical Cancer Vaccine Is Effective

Friday, 07 April 2006 12:00 AM

The new human papilloma virus vaccine provides effective protection against cervical cancer for at least 4 years, according to research from Dartmouth Medical School.

The study found that women given the GlaxoSmithKline vaccine, Cervarix, had high levels of antibodies against two of types of the virus for up to 4.5 years after receiving the last dose.

"These findings set the stage for widescale adoption of HPV vaccination for prevention of cervical cancer," said Dr. Diane Harper headed the trial.

Cervical cancer is one of the most common cancers in women. Each year 470,000 women around the world are diagnosed with the disease and 230,000, mostly in the developing world, die, according to experts.

Harper and her team followed up 800 women who took part in the original trial of the vaccine in which it was compared to a placebo. Women given the vaccine not only had high levels of antibodies, but the levels did not decrease over time.

"The results show sustained immune response and long-term efficacy," Harper said.

The research appears in the Lancet.

110

© 2019 Newsmax. All rights reserved.

   
1Like our page
2Share
Pre-2008
The new human papilloma virus vaccine provides effective protection against cervical cancer for at least 4 years, according to research from Dartmouth Medical School. The study found that women given the GlaxoSmithKline vaccine, Cervarix, had high levels of antibodies...
Cervical,Cancer,Vaccine,Effective
176
2006-00-07
Friday, 07 April 2006 12:00 AM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved